$600M TO Advance Immunotherapy

Friday, June 15th, 2018

An ONAMI funded company, Tomegavax is now part of San Francisco-based Vir Technologies.

Tomegavax/Vir's technology was developed at the Vaccine and Gene Therapy Institute on OHSU's west campus

An ONAMI funded company, Oregon Health and Sciences spinout, and OTRADI Bioscience Incubator tenant, Tomegavax is now part of San Francisco-based Vir Technologies, backed by $600M in investment from the Gates Foundation, Arch Venture Partners and Softbank. The company is continuing its technology development in Portland.

Read More